Trials / Active Not Recruiting
Active Not RecruitingNCT06008977
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- AdventHealth Translational Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study will be to provide i) information on feasibility implementing an exercise intervention trial among patients with cutaneous cancers, including melanoma, squamous cell carcinoma (cuSCC), and Merkel cell carcinoma, scheduled to receive checkpoint blockade immunotherapy, and ii) preliminary data on the impact of a day-of-therapy exercise intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise Test | Supervised pedaling on an ergometer (stationary bike) at a moderate pace for a goal of 30 minutes. The exercise test will be scheduled at infusion visits 1, 6, and 12 or 1 and 3 over the treatment cycle, depending on the group assignment. |
Timeline
- Start date
- 2024-06-03
- Primary completion
- 2025-08-07
- Completion
- 2026-12-01
- First posted
- 2023-08-24
- Last updated
- 2026-03-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06008977. Inclusion in this directory is not an endorsement.